Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05561374
Title Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients With Recurrent High-Grade Glioma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Oblato, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Providence Saint John's Cancer Institute Santa Monica California 90404 United States Details
Norton Healthcare Louisville Kentucky 40202 United States Details
Atrium Health Wake Forest Baptist Comprehensive Cancer Center Winston-Salem North Carolina 27157 United States Details
The University of Oklahoma Health Sciences Center, Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field